American Oncology Network partners with Humana, Evolent to reduce cancer care prior authorizations

Bitget2026/11/10 17:19

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

American Oncology Network, Humana and Evolent launched a cancer care model across clinics in eight states to reduce reliance on prior authorization.
Practices meeting quality and evidence-based treatment standards will no longer need traditional prior authorization for most anticancer drug therapies.
The collaboration aims to improve treatment timeliness, quality and affordability through clinical pathways, quality improvement programs and provider performance reporting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

American Oncology Network partners with Humana, Evolent to reduce cancer care prior authorizations

You may also like

Crypto prices